thyrotropin
Showing 1 - 25 of 144
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Thyroid Cancer Trial in New York (Thyrotropin Releasing Hormone (TRH), levothyroxine, Hypothyroidism QOL questionnaire)
Recruiting
- Thyroid Cancer
- Thyrotropin Releasing Hormone (TRH)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 12, 2022
Differentiated Thyroid Cancer Trial in Beijing (124I PET/CT)
Recruiting
- Differentiated Thyroid Cancer
- 124I PET/CT
-
Beijing, Beijing, China
- +1 more
May 6, 2021
Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)
Active, not recruiting
- Thyroid Carcinoma
- Vemurafenib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 28, 2022
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
Enrolling by invitation
- Thyroid Cancer
-
Cleveland, OhioCleveland Clinic
Aug 9, 2021
Subclinical Hypothyroidism Trial in Philadelphia (Levothyroxine, Liothyronine, Thyrotropin-Releasing Hormone)
Completed
- Subclinical Hypothyroidism
- Levothyroxine
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 16, 2021
Thyroid Function After Cardiopulmonary Resuscitation
Recruiting
- Heart Arrest
- +3 more
- TSH determination
- +4 more
-
Bochum, NRW, GermanyMedizinische Klinik I, Universitätsklinikum Bergmannsheil, Ruhr-
Aug 13, 2021
Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed
Unknown status
- Hypothyroidism
- Hyperthyroidism
-
Bietigheim, BW, Germany
- +2 more
Oct 6, 2020
Total Thyroidectomy, Near-total Thyroidectomy Trial in Busan, Seoul, Suwon (Period 1 GX-30, Period 2 THYROGEN®, Period 1
Completed
- Total Thyroidectomy
- Near-total Thyroidectomy
- Period 1 GX-30, Period 2 THYROGEN®
- Period 1 THYROGEN®, Period 2 GX-30
-
Busan, Korea, Republic of
- +4 more
Sep 7, 2020
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Foot, Diabetic Trial in Córdoba (Personalized Nutritional Intervention)
Not yet recruiting
- Foot, Diabetic
- Personalized Nutritional Intervention
-
Córdoba, Andalucía, SpainHospital Universitario Reina Sofía de Córdoba
Aug 4, 2022
Central Hypothyroidism, Hypothyroidism, Hyperthyroidism Trial in Basel (Indirect calorimetry, Dual energy X-ray Absorptiometry
Completed
- Central Hypothyroidism
- +2 more
- Indirect calorimetry
- +2 more
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Department of Endocrinology
May 16, 2022
Diabetes, Type 2 Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Oral semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +73 more
Jan 13, 2023
Iodine Nutrition and Thyroid Diseases in the Elderly
Not yet recruiting
- Nutrition, Healthy
- Elderly
- Naturally different iodine levels exposure
- (no location specified)
Feb 3, 2023
Thyroid Diseases Trial in Madison (Prednisone)
Completed
- Thyroid Diseases
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Oct 4, 2022
Selenium Deficiency, Thyroid Cancer TNM Staging, Recurrence Trial in Jinan (Selenium Yeast, Placebo)
Not yet recruiting
- Selenium Deficiency
- +3 more
- Selenium Yeast
- Placebo
-
Jinan, Shandong, ChinaThe First affiliated hospital of Shandong First Medical Universi
Mar 11, 2022
During Pregnancy in Women With Glucose Metabolic Disorders.
Recruiting
- Diabetes Mellitus, Type 2
- +6 more
- No interventions
-
Aarhus, Aarhus N, Denmark
- +2 more
Nov 22, 2022
Endocrine and Metabolism in Patients With Thalassemia Major
Recruiting
- Thalassemia Major
-
Taipei, TaiwanShyang-Rong Shih
Feb 16, 2021
Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)
Recruiting
- Thalassemia
- Iron Overload
- CN128 Tablets
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022
Healthy, Pituitary Disease, Thyroid Disease Trial run by the NIDDK (TRH (Thyrotropin Releasing Hormone))
Completed
- Healthy
- +2 more
- TRH (Thyrotropin Releasing Hormone)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 11, 2018
Quality of Life After Interventional Thyroid Treatment
Completed
- Thyroid; Deficiency
- Quality of Life
- Levothyroxine Sodium
-
Luedenscheid, NRW, GermanyDepartment of Nuclear Medicine Klinikum Luedenscheid
Mar 28, 2022
Thyroid Function After Syncopation and Seizure
Recruiting
- Syncope
- Seizures
- Evalution of thyroid function
-
Bochum, NRW, Germany
- +3 more
May 19, 2021